With 9,149 patents held between 2002 and 2022, Pfizer Inc holds the most number of Rare Diseases patents in the Healthcare sector in the Europe region.
The second largest number of patents were held by F. Hoffmann-La Roche Ltd with 6,700 Rare Diseases patents. The third largest number of patents were held by Sanofi with 5,507 Rare Diseases patents, of which 23.9% was contributed by Aventis Pharma SA. The fourth largest number of patents were held by Johnson & Johnson with 4,217 Rare Diseases patents, of which 50.4% was contributed by Janssen Pharmaceutica NV. The fifth largest number of patents were held by Novartis AG with 3,994 Rare Diseases patents.
The top five patents holders, i.e., Pfizer Inc, F. Hoffmann-La Roche Ltd, Sanofi, Johnson & Johnson, and Novartis AG, together held 29,567 Rare Diseases patents during the period.
United States of America
China
Switzerland
United States of America
United States of America
United States of America
United States of America
United States of America
United States of America
Japan
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer